Zoe Arvanitakis
Psychiatry and Mental health · 2004–2019
A researcher in the Science corpus: 7 papers; trusts 8 researchers and is trusted by 4 researchers here, as inferred from the citation graph.
Subfields
- Psychiatry and Mental health — 63 citations into it; #496 of 1,338 by trust here, #114 by citations
- Physiology — 62 citations into it; #1,046 of 2,276 by trust here, #494 by citations
Whom Zoe Arvanitakis trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
- R. Wilson
- Julie A. Schneider
- David A. Bennett
- Lisa L. Barnes
- L. Beckett
- Denis A. Evans
- Ronald C. Petersen
- H. Braak
Who trusts Zoe Arvanitakis overall
- Clifford R. Jack Jr.
- David A. Bennett
- Julie A. Schneider
- Reisa A. Sperling
- C. Iadecola
- Bruce S. McEwen
- A. Serrano‐Pozo
Papers from Zoe Arvanitakis's perspective
Ordered by how strongly the researchers Zoe Arvanitakis trusts endorse each paper. Same corpus, a different order for every researcher.
- Natural history of mild cognitive impairment in older persons (Neurology)
- Rate of progression of mild cognitive impairment to dementia – meta‐analysis of 41 robust inception cohort studies (Acta Psychiatrica Scandinavica)
- Increased risk of type 2 diabetes in Alzheimer disease. (Diabetes)
- Diet‐induced insulin resistance promotes amyloidosis in a transgenic mouse model of Alzheimer's disease (The FASEB Journal)
- Defects in IGF-1 receptor, insulin receptor and IRS-1/2 in Alzheimer's disease indicate possible resistance to IGF-1 and insulin signalling. (Neurobiology of Aging)
- Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease – is this type 3 diabetes? (Journal of Alzheimer's Disease)
- An anti-diabetes agent protects the mouse brain from defective insulin signaling caused by Alzheimer's disease- associated Aβ oligomers. (Journal of Clinical Investigation)
- The Diabetes Drug Liraglutide Prevents Degenerative Processes in a Mouse Model of Alzheimer's Disease (Journal of Neuroscience)
- Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (Diabetes Care)
- A comprehensive definition for metabolic syndrome (Disease Models & Mechanisms)
Their papers
- Demonstrated brain insulin resistance in Alzheimer's disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline. (2012) — 1,731 citations
- Diagnosis and Management of Dementia: A Review (2019) — 1,153 citations
- OVERVIEW AND FINDINGS FROM THE RELIGIOUS ORDERS STUDY (2012) — 669 citations
- The Neuropathology of Probable Alzheimer's Disease and Mild Cognitive Impairment (2009) — 936 citations
- Mixed brain pathologies account for most dementia cases in community-dwelling older persons (2007) — 1,797 citations
- Neuropathology of older persons without cognitive impairment from two community-based studies (2006) — 1,292 citations
- Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function. (2004) — 1,267 citations